Leading pharmaceutical and diagnostic companies are committed to advancing innovation and improving outcomes in lung cancer care.
Renowned clinical experts and researchers who guide evidence generation, share best practices, and shape the future of lung cancer management.
Dr. Aaron Tan
Medical Oncologist, Division of Medical Oncology, National Cancer Centre Singapore & DukeNUS Medical School, National University of Singapore
Dr. Abhishek Shankar
Assistant Professor, Radiation Oncology, All India Institute of Medical Sciences, Delhi, India
Dr. Frederic Ivan Leong Ting
Head of Cancer Research - Corazon Locsin Montelibano Memorial Regional Hospital (CLMMRH) Cancer Care Center
Associate Prof. Herbert Loong
Chair, Asia Pacific Coalition Against Lung Cancer (APCLC)
Dr. Jemma Arakelyan
Medical Oncologist, PhD, CEO at the Institute of Cancer and Crisis; Advisor at Immune Oncology Research Institute; Cancer Researcher at the Laboratory for Synthetic Chemistry and Chemical Biology (LSCCB)
Dr. Kenneth G. Samala
Clinical Associate Professor, Division of Medical Oncology, Department of Medicine, University of the Philippines, Manila-College of Medicine
Dr. Yeon Wook Kim
Assistant Professor, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of MedicinePatient advocates who bring the voice of those affected by lung cancer, ensuring that care is patient-centered and access is equitable.
Mr. Mark Brooke
Chief Executive Officer, Lung Foundation Australia
Ms. Liu Yi Ting
Director of Marketing & Branding Center, MeetHealth Patient Community China
Mr. Kazuo Hasegawa
Chairman, NPO One Step - Lung Cancer Patients' Association JapanGlobal and regional organisations with shared goals in advancing lung cancer care, collaborating to amplify collective action and achieve synergistic impact.
If you would like to learn more about us or join our efforts to improve lung cancer outcomes in the Asia Pacific region, please contact us.
We are a collaborative multilateral effort focused on improving lung cancer outcomes in the Asia-Pacific region through policy reforms.
